key: cord-1005358-ge409trt authors: nan title: Rats date: 2013-12-31 journal: Clinical Veterinary Advisor DOI: 10.1016/b978-1-4160-3969-3.00138-4 sha: 11dc5e8970581b2744d9a935c0ce6eddded73073 doc_id: 1005358 cord_uid: ge409trt nan • Labored breathing • Reduced appetite • Lethargy • Recent purchase from a pet store PHYSICAL EXAM FINDINGS • Red staining around the eyes and nostrils, and occasionally the forepaws (from wiping the nares) • Usually clinical signs are associated with nutritional deficiencies, chronic physiologic stress (e.g., disease), chronic light exposure, or dacryoadenitis. • Any disease or condition that results in chronic stress will result in chromodacryorrhea. • Harderian glands of rodents with "red tears" exhibit a variety of histological autofluorescence patterns. In addition, their secretions are also affected by protoporphyrin binding to lipids, affecting fluorescence.  Inflammation of the harderian gland (i.e., dacroadenitis) causes an increase in secretions. The most common cause is infection with SDAV, a coronavirus of rats.  The tears are secreted via activation of the parasympathetic nervous system via muscarinic receptors. Anticholinergic drugs have been shown to block secretions.  Harderian glands' secretions predominantly contain lipids that act as pheromones. The presence of porphyrins in Harderian gland secretions is more the exception than the rule when describing these secretions in rodents. Generally, porphyrins give color to secretions. • Wood's lamp examination reveals bright orange-red fluorescence; allows differentiation from dried blood • Further diagnostics will dependent on the clinical signs and suspected primary underlying disease, such as respiratory tract disease (see Respiratory Tract Disease, Acute, and Respiratory Tract Disease, Chronic). Many clients will present in distress because their pet is "bleeding from the eyes." They will be relieved to know that their pet is not actually bleeding but will need to understand that this clinical sign can be an indicator of a greater underlying disease that warrants investigation. Chromodacryorrhea is not an actual disease in most cases but an indicator for an underlying problem or stress. Respiratory Tract Disease, Acute Respiratory Tract Disease, Chronic Histologically, most are mammary fibroadenomas, although adenocarcinomas are also seen. Rats have 12 mammary glands along the mammary chain, which extends from the cervical region to the tail base. Mammary tumors can arise in any of these locations. • Older animals are most frequently affected (>1 year of age). • Females are at higher risk than males; an incidence of 2% to 16% has been reported experimentally in male rats. GENETICS AND BREED PREDISPOSI-TION In inbred rat strains susceptible to mammary tumors expression levels of several prolactin-regulated genes are significantly elevated (e.g., messenger RNA's encoding prolactin and its cell surface receptor are amplified) indicating the presence of increased prolactin signaling in the mammary glands of mammary tumor susceptible rat strains. • Sex: females at higher risk than males • Age: higher risk at greater than 2 years of age • Nutrition: increased incidence with high-fat diets, reduced incidence with food restriction to that of rats on the seventh day postpartum. Because of this, rats with prolactin-secreting pituitary tumors are at increased risk of mammary tumor development. • In aging rats, prolactin secretion is increased and is reflected in the high blood prolactin level in both sexes. This change is due to a reduction of hypothalamic dopamine activity. The escape from hypothalamic inhibitory control leads to lactotroph hyperplasia and a high incidence of prolactin cell adenomas in old rats. • Gene expression of spontaneous fibroadenomas and adenocarcinomas compared to a normal rat mammary gland in the same developmental state has shown that fibroadenomas do not progress to adenocarcinoma. • Adenocarcinomas arise de-novo (i.e., without prior adenoma stage) and represent fewer than 10% of mammary tumors in pet rats. • Fibroadenomas can reach 8-10 cm in diameter and do metastasize. • Dermal/subcutaneous abscess (e.g., from bite wounds, foreign body penetration) • Neoplasia (e.g., lymphoma) • Mastitis • Fine-needle aspirate: caution during interpretation because large mammary tumors may be necrotic and can be difficult to differentiate from an abscess on cytology • Blood work: complete blood count and serum biochemistry screening as a preoperative workup • Thoracic radiographs/CT: preoperative workup if underlying respiratory disease is suspected • Stabilization of the patient if septic or has suffered blood loss • Complete surgical removal of the tumor (mastectomy) and prevention of recurrence • If necessary, stabilization of the patient if mammary tumor is infected/sepsis is present, or if blood loss has ensued from ulceration of the mass. • Complete surgical removal of the tumor and any ulcerated/infected skin or tissue is the treatment of choice.  Because tumors may be quite large, closure of dead space is important to prevent seroma formation.  Some masses are difficult to remove if they are in close association with the vulva. • Concurrent ovariectomy is recommended if patient is stable. Because recurrence of mammary tumors at different locations can frequently occur, repeated surgical removal might be necessary. Rats are notorious for mutilation of surgical sites, so appropriate pain medication with monitoring is compulsory. Use of an E-collar is necessary in some cases to prevent mutilation. Tumors are likely to recur in other mammary glands in both male and female rats, especially if ovariectomy is not performed at the same time. Constant monitoring and palpation of the mammary glands are important. • In general, survival following mastectomy is good. • Quality of life is improved post mastectomy; however, controversy continues over whether tumor removal actually prolongs survival time. • Death can occur with sepsis or blood loss if the mammary mass is not surgically removed and becomes ulcerated or infected. • To date, the only proven treatment and prevention of mammary tumor development consists of surgical removal of the tumor and ovariectomy. Other treatments have been discussed but have not proven to be effective in preventing recurrence of spontaneous tumors or in decreasing their size once present. • Cabergoline is a prolactin inhibitor that suppresses pituitary prolactin secretion and can be given orally. It has been successfully used in the palliative treatment of a pituitary adenoma in a rat at a dose of 0.6 mg/kg PO q 72 h, and thus may be helpful in rats that have mammary tumor development secondary to prolactin-secreting pituitary tumors and in those unable to undergo ovariectomy. • Gonadotropin-releasing hormone (GnRH) agonists  Deslorelin implants (4.7 mg) have been used experimentally to suppress estrus in rats for 1 year and may be useful in rats that cannot be ovariectomized.  Leuprolide acetate has been experimentally shown to suppress the ability of the pituitary-gonadal system to secrete gonadotropin and testosterone for over 5 weeks; similar to deslorelin because it may be useful in rats that cannot undergo ovariectomy • Melatonin induces apoptosis of rat prolactin-secreting tumors. Experimentally, SC melatonin administration in experimentally induced tumor-bearing rats significantly increased survival time and reduced prolactin levels but did not change the mammary tumor growth rate. • Tamoxifen: antiestrogen used in the treatment of human breast cancer. This agent would be useful only in mammary adenocarcinomas that are estrogen receptor positive. This drug is NOT recommended, given the low incidence of adenocarcinoma in rats and the fact that it has been shown to induce hepatic cancer and proliferation of the rat uterus. Histopathologic examination of removed tumors should be performed because spontaneous mammary adenocarcinoma has a 5%-10% incidence. Individual genetic variability and environmental factors such as nutrition and maternal effects in utero and during lactation most likely affect quantitative trait loci (QTL) that control susceptibility to mammary adenocarcinoma. However, the individual genetic traits and QTL that influence gene function have not yet been elucidated. • Ovariectomy of female rats by 90 days of age • Treatment of prolactin-secreting pituitary tumors • All clients who own female rats should be educated about the importance of ovariectomy before 90 days of age. • Additionally, clients should be educated on the importance of early detection and removal of tumors before they become too large to be safely removed surgically. Kidney or renal disease is a general term that describes any damage that reduces the functioning of the kidney. • Kidney disease: renal disease, kidney disease, kidney failure, chronic renal failure, nephropathy, suppurative pyelonephritis, suppurative nephritis • Chronic progressive nephrosis in rats: progressive renal disease in rats, progressive glomerulonephrosis, old rat nephropathy, glomerulosclerosis • Nephrocalcinosis: renal tubular mineralization Large mammary fibroadenoma on a female rat. Note the close proximity to the left hind leg which impeded normal ambulation. lesions are more severe in rats over 12 months of age. • Nephrocalcinosis is more common in females and can be found in animals as young as 7 weeks of age. Blood estrogen levels may play a role in that the disease can be prevented by ovariectomy and is induced in castrated male and female rats by estrogen administration. GENETICS AND BREED PREDISPOSI-TION A significantly higher prevalence of chronic progressive nephrosis is seen in the Sprague-Dawley strain of rat. Osborne-Mendel and Buffalo strains are relatively insusceptible. Elevated prolactin levels are suspected of contributing to more severe disease. • With any diagnosis of renal insufficiency or failure, prognosis varies with severity of clinical pathologic findings, duration of disease, and severity of primary renal failure. If secondary to infection or obstructive disease, prognosis is determined by duration of the disease process and success in treatment-medical or surgical-of the underlying condition of secondary renal insufficiency. • Depending on initial diagnosis, disease severity, and response to therapy, quality of life issues and euthanasia should be discussed with the owner in terms of any patient with renal disease. • Many different terms are used to describe renal function and its deterioration.  Azotemia refers to increased concentrations of urea nitrogen and creatinine and other nonproteinaceous nitrogenous waste products in the blood. Renal azotemia denotes azotemia caused by renal parenchymal changes.  Uremia is the presence of all urine constituents in the blood. Usually a toxic condition, it may occur secondary to renal failure or postrenal disorders, including urethral blockage.  Renal reserve may be thought of as the percentage of "extra" nephrons-those not necessary to maintain normal renal function. Although it probably varies from animal to animal, this value is greater than 50% in most mammals.  Renal insufficiency begins when the renal reserve is lost. Animals with renal insufficiency outwardly appear normal, but have a reduced capacity to compensate for stresses such as infection or dehydration and have lost urine concentrating ability.  Renal failure is a state of decreased renal function that allows persistent abnormalities (azotemia and inability to concentrate urine) to exist; it refers to a level of organ function rather than a specific disease entity. Acute renal failure generally refers to cases of sudden decline of glomerular filtration rate resulting in an accumulation of nitrogenous waste products and inability to maintain normal fluid balance. Chronic renal failure generally refers to an insidious onset with slow progression (usually months to years) of azotemia and inadequately concentrated urine. • It is important to realize that most of the renal diseases discussed can manifest as varying stages of compromise in renal reserve, renal insufficiency, or renal failure. If or when the disease process progresses depends on variables such as the specific disease in question, environmental factors, and the individual animal itself. • NTP-2000 open formula is one diet available in laboratory medicine that is low in protein (14.0%) and has a Ca:P ratio approximating 1.3 : 1; it has been found to decrease the incidence of nephrocalcinosis in rats. • Another laboratory rat diet, AIN-93G, has a lower phosphorus content (0.3%) and a higher Ca:P ratio and has been shown to lower the incidence of nephrocalcinosis. have an effect on hypertension associated with hydronephrosis in rats. Hydronephrosis as a result of partial ureteral blockage led to increased blood pressure, which worsened significantly on a high-salt diet versus a low-salt diet. • High levels of dietary soy isoflavones induced nephrocalcinosis formation, depending on the strain of laboratory rat. Chronic renal failure requires continuous treatment and monitoring. Unless a specific underlying cause is diagnosed and treated successfully, treatment in many cases will be lifelong. Oral doxycycline should not be given with any dairy products or other products containing calcium because this will decrease its bioavailability. • Patients with severe disease should be hospitalized until they are able to go home on oral medications. • Patients should be closely monitored for signs of chronic respiratory disease. Little is known about the prognosis of pure acute bacterial pneumonia because co-infection with other respiratory pathogens is common, as are subclinical infections. Because both of these bacteria can be present without causing clinical disease, preventive measures are focused on decreasing stress, avoiding immune suppressive drugs, and maintaining appropriate diet/husbandry to avoid conversion to clinical disease. All clients owning rats should understand the frequency of respiratory disease in rats and the importance of proper housing (good ventilation, avoidance of crowding, avoidance of dusty bedding such as wood shavings) and close observation for any signs of respiratory disease, so that treatment can be administered as soon as possible. Oral doxycycline should not be given with any dairy or other products containing calcium because this will decrease its bioavailability. • Respiratory rate and effort • Body weight/condition • Appetite Because many factors contribute to rat respiratory issues, the disease cannot be eliminated, but clinical signs may be ameliorated with antibiotics and supportive care. • Use of corticosteroids as antiinflammatory agents has been recommended to decrease the inflammation. Most (experimental) studies in rats have found steroids do not affect signs, function, and indices of inflammation. There is also significant concern that corticosteroid efficacy will be accompanied by consequential impairment of the rat's immune defenses leading to fatal pulmonary abscessation and/or pneumonia. • Use of bronchodilators (both oral and inhaled) has been recommended because these agents are helpful in humans with chronic bronchitis. Specific studies with bronchodilators have not been performed in rats with chronic respiratory disease, but they may be helpful. • Nebulized hypertonic saline solution (7%) has been used successfully in humans with cystic fibrosis as a mucolytic agent. It breaks down the mucous biofilm and gives relief for ~8 hours. • Concurrent nebulization with bronchodialators and/or antibiotics has been recommended to directly deliver medications. Specific studies using these nebulizations have not been performed in rats with chronic respiratory disease but may be helpful. This disease complex (M. pulmonis) is thought to be ubiquitous in pet rats; thus prevention of infection is nearly impossible. Preventing contributing factors such as proper ventilation, bedding, and diet and decreasing stress can be helpful. All clients who own rats should be educated about the ubiquitous nature of M. pulmonis and the importance of ventilation, low cage ammonia levels, avoidance of dusty bedding such as wood shavings, and appropriate nutrition in decreasing the potential severity of chronic respiratory disease in rats. • Ringtail  Occurs in young rats (7-19 days) and is characterized by dry skin and formation of annular constrictions, which might progress to swelling, and tissue necrosis. Autoamputation might occur.  Low environmental relative humidity (less than 20%-40%) appears to be the cause; it is more often seen in rats housed in hanging cages and is rarely seen in pet rats. • Treat primary and secondary infections. • Promote healing of skin lesions • If animal is self-mutilating: shorten and blunt nail tips. In severe case, temporarily apply bandages to hindfeet. Apply E-collar to prevent removal of bandages. Good to fair • Provision of a commercial diet • Quarantine all new incoming animals for a minimum of 30 days before allowing contact with other animals. Dermatophytes are contagious; clients should seek medical advice if lesions are found on humans in the household. Skin Disease Skin lesions located over the shoulder and neck area, which were induced by fighting with cage mates. Isolation of the rat led to complete resolution of the skin lesions. Self-trauma, secondary to ectoparasite induced pruritus, can present in similar fashion.